The relative importance of the specific immunological mechanism used by the host to protect itself against a viral infection depends, at least in part, upon the route by which the virus spreads from one cell to another. Virus can spread by one or more of three different routes: extracellularly, from infected cells to nearby or distant uninfected cells (type 1 spread); directly from infected to contiguous uninfected cells as a result of cell fusion or viral budding (type 2 spread); or from parent to progeny cells during cell division (type 3 spread) (11) . In general, it appears that neutralizing antibody can stop type 1 but not type 2 or 3 spread. Very little, however, is as yet known about the mode of spread of most viruses. The present investigation was initiated to determine the mode of spread of several common viruses and to study in greater depth the factors responsible for the persistence of one of these viruses (foamy virus) in the presence of neutralizing antibody.
MATERIALS AND METHODS
Viruses and cell cultures. Simian foamy virus (SFV) types 1 and 2 were obtained from the National Cancer Institute Reagent Branch, and SFV types 6 and 7 were isolated from chimpanzee tissues (6) . The foamy viruses, herpes simplex virus (HSV) type 1, vesicular stomatitis virus (VSV), simian virus 5 and vaccinia viruses were propagated in primary or first subcultured rabbit kidney cells (PRK). Coxsackievirus B1, encephalomyocarditis virus, mumps virus, and measles virus were propagated in Vero cells. Human cytomegalovirus (CMV) (AD169) and murine CMV were propagated in WI-38 and primary mouse embryo cells, respectively. Cell cultures were maintained with Eagle minimal essential medium supplemented with penicillin (100 U/ml), streptomycin (100 x 106 ,ug/ml) and 2 to 10% fetal bovine serum inactivated at 56°C for 30 min. Newcastle disease virus (NDV) was propagated in the allantoic fluid of embryonating hen eggs.
Formation of viral plaques in the presence of antibody. Standard agar overlay plaque techniques were used with coxsackie, mumps, SV5, vaccinia, CMV (murine), and measles viruses, whereas methylcellulose overlay techniques were used with EMC, VSV, CMV (human), and HSV. Antibody was prepared in rabbits, and the 50% neutralization titer was determined. In a typical experiment, virus was allowed to adsorb to the monolayers for 2 h, the plates were washed, and the appropriate overlay media and antibody concentrations were added. The viral plaques were counted 2 to 8 days later, depending upon the virus studied.
Assay for foamy viruses. The PRK cells were treated with a mixture of 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) and resuspended in maintenance medium at a concentration of 1 x 105 to 2 x 105 cells/ml. The cells in a 1-ml volume were seeded onto 35-mm tissue culture dishes (Falcon plastic) and incubated at 36°C in a 5% CO2 atmosphere. After 24 h, the cells were infected with 10-fold serial dilutions of foamy virus in a 0.5-ml volume and incubated for 90 min at 36°C on a rocker. The inocula were then aspirated, and the antibody overlay medium consisting of specific antiviral rabbit sera and maintenance media was added (1 to 2% rabbit anti-foamy virus serum containing approximately 25 neutralization units and 5 to 8% fetal bovine sera). Antibody overlay medium can be added within the first 24 h after viral incubation. The cell cultures were refed after 3 to 4 days of 1172 on October 26, 2017 by guest http://iai.asm.org/ Downloaded from incubation. After 8 to 10 days of incubation, medium was aspirated and the cells were fixed with 95% ethanol, stained with 20% Giemsa, washed in tap water, and allowed to air dry. Plaques were read on a plaque counter. The size and number of plaques increased until day 8; after this time there was little change in the number or size of plaques.
Fluorescent microscopy and '25I-labeled antibody. The basic procedures for fluorescent antibody and 125I-labeled antibody techniques have been described (5) . New Zealand white rabbits were immunized by repeated intravenous inoculations with partially purified SFV-1 or SFV-7 virus pools (6) . Virus-immune serum and sera from unimmunized animals was precipitated with ammonium sulfate. Immunoglobulin G (IgG) fractions were separated on a Sephadex G-200 column and labeled with 1251 or fluorescein isothiocyanate.
Cells grown on cover slips were infected with SFV-7 at an input multiplicity of 3 plaque-forming units/cell. After an adsorption period of 2 h at 37°C, the inoculum was removed, the monolayers were washed, fresh culture medium was added, and the cells were placed at 37°C. At various times after infection, cover slips were removed and washed with phosphate-buffered saline, and half of the cover slips were fixed with acetone for 5 min at room temperature. Fixed cells were used to detect cytoplasmic and nuclear antigen, and unfixed cells were used to detect membrane antigens. Cells were incubated with either '251-labeled or fluorescein-labeled antiviral IgG. The cover slips were washed, and the amount of 125I-labeled antiviral IgG that bound to the cells was determined. Cover slips were mounted on slides and observed through a Zeiss fluorescent microscope with a UG-IP exciter filter system. The approximate percentage of cells showing specific fluorescence and localization of the fluorescence was then determined.
Attempts to detect capping of viral antigens on the cell surface were carried out at various intervals after infection. Monolayers were treated with EDTA and 0.2-ml volumes of cell suspensions were mixed with fluorescein isothiocyanate-labeled antiviral IgG. The mixtures were incubated for 20 min at 37°C, washed, resuspended in culture media, and placed at 37°C. After 20, 40, 60, and 120 min of incubation, the cells were removed and observed with the fluorescent microscope.
Complement-mediated cytotoxicity. For complement-mediated cell lysis studies, PRK cells seeded in petri plates, but without cover slips, were infected with SFV-7 or HSV, as described above. After 5, 24, 48, and 72 h of incubation, the cells were washed with phosphate-buffered saline, and 1 ml of rabbit anti-SFV serum or anti-HSV serum was added. Each serum had a neutralizing antibody titer of 1:2,000. Controls consisted of uninfected cells incubated with immune sera and infected cells incubated with nonimmune sera. The sera were removed after 1 h of incubation at 35°C in 5% C02, and fresh or heat-inactivated complement (guinea pig and rabbit) was added. After an additional 1 1 of incubation, cells were washed and removed with a trypsin-EDTA mixture, and the viable cell count was determined with trypan blue (0.05%) (4). These experiments also were performed adding the serum and complement simultaneously (2) .
Interferon assay. Interferon activity was assayed by reduction of VSV plaque formation on PRK cells. The titer of interferon activity of a given sample is expressed as the reciprocal of the highest dilution that reduced VSV plaques by 50%. Standard rabbit serum interferon containing 2 x 104 IU/ml was obtained from the National Institute of Allergy and Infectious Diseases and contained the same number of interferon units in our assay system.
RESULTS
Viral spread in the presence of neutralizing antibody. The effectiveness of antiviral antibody in preventing the development of viral plaques when added after the viral absorption period is shown in Table 1 . The development of plaques by coxsackie B1 virus, encephalomyocarditis, VSV, mumps virus, and SV5 was completely inhibited by antibody. In contrast, antibody did not inhibit plaque formation by vaccinia, HSV-1, and human and murine CMV. Since an absorption period of only 2 h was used with human CMV-infected cultures, the decreased number of plaques may have been due to neutralization of partially absorbed virus. Similarly, low concentrations of neutralizing antibody did not inhibit the formation of plaques by measles virus, SFV-1 and SFV-7; high concentrations of neutralizing antibody, however, did inhibit the formation of plaques by measles and partially inhibited the formation of plaques by SFV. SV5 plaque formation was tested only at relatively high concentrations of antibody (100 U). The possibility exists that plaque formation would not be inhibited by lower concentrations of antibody. In other experiments (data not shown) in which coxsackie, measles, SV5, and SFV plaque formation was suppressed by antibody, the reappearance of virus was studied after the removal of antibody. No virus could be recovered from coxsackievirus-infected cultures, but virus could be recovered from cultures that had been infected with measles, SV5, and SFV, indicating that antibody had not cured the latter cultures. The foamy virus group then was selected for further in depth analysis.
Effect of antiviral antibody on foamy virus spread. To evaluate the effect of different concentrations of antiviral antibody on the formation of plaques, PRK cells were inoculated with SFV-7 and then overlayed with antibody. Approximately the same number of plaques developed in the presence of 1 or 125 U of antibody Cytomegalovirus ( TMTC  1  27  128  21  256  10 a Different viruses were allowed to adsorb on cell monolayers for 2 h. The plates were washed, and the appropriate overlay medium (agar or methylcellulose) was added either alone or mixed with antiviral antibody. Plaques were counted 2 to 8 days later, depending upon the virus studied.
bAntibody in overlay medium is expressed in terms of units of neutralizing antibody; 1 unit is equivalent to the concentration of antibody that neutralized 50% of the viral plaques.
" TMTC, Too many to count. For the SFV-infected cultures, the overlay medium that contained no antibody was just maintenance medium (rather than agar on methylcellulose). In the presence of medium alone, the viral spread was so extensive that discrete plaques could not be counted.
( The antiserum overlay medium was prepared in maintenance medium supplemented with anti-SFV-7 rabbit serum and with normal rabbit serum so that all of the dishes were incubated with medium containing 20% serum. After 10 days of incubation, the plaques were read and the average plaque number of four dishes was recorded.
formed and the time required for plaque development varied with the concentration of cells in the monolayer (Table 3) . Maximal size and number of plaques were obtained when 1 x 105 to 3 x 105 cells were seeded onto dishes. If higher concentrations of cells were used (5 x 105 to 1 x 106), the development of cytopathic effect was delayed by 2 days, and the size and number of plaques were decreased. The development of maximal numbers of plaques in the presence of relatively low numbers of cells (i.e., noncontact inhibited) may simply reflect the fact that cell division is required for foamy virus replication (14) .
Time of appearance of virus-induced cell surface antigens. To determine if the foamy viruses induced antigens on the surface of infected cells, PRK cells were infected with SFV-7 at an input multiplicity of 3 plaque-forming units/cell. After incubation for 5, 24, 48, and 72 h, the presence of specific intracellular and membrane fluorescence was determined (Table  4) . Intracytoplasmic and nuclear fluorescence was noted in nearly all of the cells at 24 to 72 h. The intensity of nuclear fluorescence decreased slightly after 24 h, whereas brilliant cytoplasmic fluorescence was still present at 72 h. The intensity of the membrane fluorescence was maximal at 24 to 48 h but had decreased by 72 h. Foamy virus antigens, present on infected cell membranes, were dispersed over the whole cell membrane but appeared patchy in comparison with antigens induced by HSV-1 or vaccinia virus that served as controls. Attempts to cap foamy virus antigens with anti-foamy virus antibody were unsuccessful. Growth curve studies showed that the highest virus yield was obtained at 48 h after infection for both cell-associated virus and virus present in the extracellular culture fluid. Neg Neg Neg a PRK cells grown on cover slips in 35-mm petri dishes were infected with SFV-7 with an input multiplicity of 3 plaque-forming units (PFU)/cell. The infected cells were sequentially followed by light microscopy, immunofluorescence, infectivity, complement-mediated lysis, and capping. Neg, Negligible.
bHours after infection.
c Intensity of immunofluorescence is graded from + to + + +. Role of interferon. Studies were performed to determine whether the foamy viruses induced interferon. PRK cells were infected with SFV-1, SFV-2, SFV-6, and SFV-7. Foamy virus cytopathic effect was first noted at 2 days and progressed to involve 80 to 100% of the cells by day 7 . At various times after infection (1, 2, 3, 4, and 7 days), the supernatant fluids were assayed for interferon activity. Interferon activity was never detected in supernatant fluids tested at a 1:5 dilution. In contrast, supernatant fluids from NDV-infected cultures contained more than 8,000 U of interferon as early as 24 h after infection.
In another experiment, SFV, HSV, and NDV were ultraviolet inactivated and added to PRK cell cultures. Supernatant fluids were removed after 24 h and assayed for interferon activity. Interferon activity was found in NDV-treated cells (320 U) but was not found in cultures treated with HSV or SFV.
In an attempt to use a more sensitive assay to detect interferon activity, ultraviolet-inactivated viruses were added to PRK monolayers, and after 24 h the medium was removed and the monolayers were infected with 25 plaque-forming units of VSV. The PRK cells, treated with ultraviolet-inactivated NDV or HSV-1, were protected when challenged with VSV (Table 6) . However, PRK cells treated with ultravioletinactivated SFV were not protected when challenged with VSV.
To determine if foamy viruses were sensitive to the antiviral action of interferon, PRK cells were treated with dilutions of interferon for 24 h and then challenged with VSV, HSV-1, SFV-1, SFV-2, and SFV-7. One unit of interferon inhibited more than 50% of VSV plaques (Table  7 (250 to 500 neutralization units) moderately inhibit plaque formation, the cultures were not free of virus or "cured." A number of factors might be responsible for this partial inhibition of viral spread by very high concentrations of antibody. Transient exposure of virus to serum may take place during the egress or budding of the virus into adjacent cells, and in the presence of high concentrations of antiviral antibody this might result in neutralization. High concentration of antiviral antibody attached to the surface of infected cells also might block viral-induced cell fusion and thereby prevent cell-to-cell spread. Alternatively, high concentrations of antiviral antibody might affect the expression or synthesis of viral antigens (3).
Since neutralizing antibody does not stop the spread of foamy viruses, other immunological mechanisms such as antibody-dependent, complement-mediated lysis might be required to halt the infection. Although viral antigens were induced on the surface of foamy-infected cells, complement-mediated lysis was not demonstrated. There are several explanations. First, the cell type infected might be resistant to lysis by complement. This is unlikely, since the same cells infected with HSV could be lysed. Second, the density of viral antigens on the surface of infected cells might be a factor. If there are few antigenic sites or if these sites are widely separated, complement-mediated cell destruction may not occur (1, 10) . Our studies with fluorescein isothiocyanate-labeled and 125I-labeled antibody showed that the concentration of viral antigens on the surface of foamy virus-infected cells was, in fact, low. Third, antiviral antibody might induce fluctuations in the density of viral antigens by capping (8) . However, we were unable to demonstrate capping. Fourth, the concentration and nature of the antiviral antibody in a particular serum may vary, i.e., the ratio of complement-fixing to noncomplement-fixing antibody or the ratio of cytotoxic to noncytotoxic antibody (1) .
Whether antibody-dependent, cell-mediated cytolysis or cytotoxic T lymphocytes aid in stopping the spread of foamy virus has not yet been investigated. In fact, it is not known whether foamy viruses induce a cell-mediated immune response. Recent studies have shown that cellular immunity to viral infections may, in part, be mediated through immunologically induced interferon (13) . Our studies, however, indicate that foamy viruses are relatively resistant to the antiviral action of standard interferon and are poor interferon inducers. Whether the antiviral action of immune-induced interferon would affect foamy virus replication more than standard interferon remains to be determined. The fact remains, however, that these viruses produce a persistent infection in vivo.
It is becoming increasingly apparent that a variety of viruses can produce persistent infections in the presence of immunity. More than a dozen factors that might contribute to viral persistence in the presence of immunity have been enumerated (12) . In the case of foamy viruses, our studies suggest that the capacity of these viruses to spread from cell to contiguous cell in the presence of antibody, the patchy and widely dispersed expression of viral antigens on the cell surface, and the poor induction and response to interferon may be several of the important factors contributing to persistence.
